Skip to main content
Logo GMV

Main navigation

  • Sectors
    • Icono espacio
      Space
    • Icono Aeronáutica
      Aeronautics
    • Icono Defensa y Seguridad
      Defense and Security
    • Icono Sistemas Inteligentes de Transporte
      Intelligent Transportation Systems
    • Icono Automoción
      Automotive
    • Icono Ciberseguridad
      Cybersecurity
    • Icono Servicios públicos Digitales
      Digital Public Services
    • Icono Sanidad
      Healthcare
    • Icono Industria
      Industry
    • Icono Financiero
      Financial
    • Icono Industria
      Services
    • All Sectors

    Highlight

    Slopsquatting
    Slopsquatting: A silent threat born from the hallucinations of LLMs
  • Talent
  • About GMV
    • Get to Know the Company
    • History
    • Management Team
    • Certifications
    • Corporate Social Responsibility
  • Communication
    • News
    • Events
    • Blog
    • Magazine GMV News
    • Press Room
    • Media library
    • Latest from GMV

Secondary navigation

  • Products A-Z
  • GMV Global
    • Global (en)
    • Spain and LATAM (es - ca - en)
    • Germany (de - en)
    • Portugal (pt - en)
    • Poland (pl - en)
    • All branches and all GMV sites
  • Home
  • Communication
  • News
Back
New search
Date
  • Healthcare

GMV has teamed up with the Extremadura Health Service to develop the PoPS (Personalized Oriented Drug Prescription System) tool

12/12/2023
  • Print
Share
Proyecto MedeA

Can digital technology applied to clinical practice assist healthcare professionals in prescribing individualized pharmacological treatments? This health and sustainability challenge involves determining whether a specific medication will be effective for a patient and, if so, at what dosage, using technological tools to support healthcare professionals and avoid side effects and adverse reactions. The Extremadura Health Service (SES) has addressed this challenge through its leadership on  MedeA, a pioneering project in Spain, supported by the expertise and advanced algorithmic developments of technology multinational GMV. Specifically, GMV is actively participating in the collaborative project to create a personalized drug prescription support tool called PoPS.

MedeA is an ambitious project developed in Extremadura, as a representative subgroup of the European population, and functioning as a pilot test due to the unique characteristics of this autonomous region (a single, homogeneous healthcare system and a small population). The goal is for the project to be validated and, as Dr. Llerena has said, to subsequently expand. His personal commitment to making this project a reality is particularly commendable: the research work spans thirty years and has been laying the groundwork for the MedeA project since 2013.

The goal of MedeA is to develop technological systems that support clinical decision-making, including a Personalized Oriented Drug Prescription System.  This initiative is disruptive for three reasons: 1) its funding approach through public-private collaboration in innovative public biosanitary procurement; 2) its focus on a single healthcare system such as the Extremadura Health Service (SES), where the project is conceived as a comprehensive, cross-cutting system for the entire population, minimizing healthcare and social inequities; 3) it empowers physicians with a digitally supported prescription tool, enabling personalized therapy  decisions  by considering genetic information within the patient's medical history when determining the optimal drug combination.

Find out more
  • Print
Share

Related

Premios IA con Impacto Social
  • Healthcare
The GMV-led Tartaglia project wins the "AI with Social Impact Prize".
np_011_ia-lung-scan.jpg
  • Healthcare
Innovative artificial intelligence-based simulator for the diagnosis of interstitial lung diseases
np_011_ia-lung-scan.jpg
  • Healthcare
GMV designs a groundbreaking artificial intelligence-based simulator for diagnosing interstitial lung diseases

Contact

Alameda dos Oceanos, 115
1990-392 Lisbon, Portugal

Tel. +351 308801495
Fax. +351 213866493

Contact menu

  • Contact
  • GMV around the world

Blog

  • Blog

Sectors

Sectors menu

  • Space
  • Aeronautics
  • Defense and Security
  • Intelligent Transportation Systems
  • Automotive
  • Cybersecurity
  • Digital Public Services
  • Healthcare
  • Industry
  • Financial
  • Services
  • Talent
  • About GMV
  • Shortcut to
    • Press Room
    • News
    • Events
    • Blog
    • Products A-Z
© 2025, GMV Innovating Solutions S.L.

Footer menu

  • Contact
  • Legal Notice
  • Privacy Policy
  • Cookie Policy

Footer Info

  • Commitment to the Environment
  • Financial Information